WAKAMOTO PHARMACEUTICAL CO.,LTD.

4512

TSE PrimePharmaceuticals

¥ -

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

descriptionIncome Statement (PL) Summary

Updated: 2026-08-05FY2027 Q1

Revenue

101.6100M JPY

YoY +25.9%

Operating Income

-1.4100M JPY

YoY +4.8%

Net Income

3.4100M JPY

YoY +1148.3%

EPS

0.2JPY

YoY +106.1%

Performance Trend

Revenue, operating income and net income trend (last 5 periods)

RevenueOperatingNet Income

99.1億円

73.2億円

47.2億円

21.3億円

-4.6億円

Rev: 83.8億円Op: -13.4百万円NI: 2.4億円

Rev: 86.6億円Op: 1.4億円NI: 1.4億円

Rev: 77.4億円Op: -2億円NI: 1.1億円

Rev: 77.9億円Op: -4.6億円NI: 64.4百万円

Rev: 99.1億円Op: 2.6億円NI: 2.3億円

2022/FY2023/FY2024/FY2025/FY2026/FY

Full-Year Progress

FY2027 Q1

Net Income-

Revenue Progress24.300M

Revenue Forecast11000M

Net Income Progress-

Net Income Forecast-

Income Statement Details

Unit: JPY

Unlock Long-Term Financial Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan